<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="18518">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02155010</url>
  </required_header>
  <id_info>
    <org_study_id>2014-003</org_study_id>
    <nct_id>NCT02155010</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine in Spinal Anesthesia</brief_title>
  <official_title>Hemodynamic Effect of Dexmedetomidine on Heavy Bupivacaine Spinal Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inje University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Inje University</source>
  <oversight_info>
    <authority>South Korea: Ministry of Food and Drug Safety</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients were randomized into two groups, A group and B group. A group and B group patients
      are injected intravenous dexmedetomidine after intrathecal injection (IT) of heavy
      bupivacaine and injected intravenous dexmedetomidine before IT of heavy bupivacaine,
      respectively.

      The investigators will compare of hemodynamics and patient's comfortability between two
      groups.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A and B group patients will intravenous inject dexmedetomidine 1mcg/kg for 10 minute loading
      infusion and 0.2mcg/kg/hr for continuous infusion. A group receive intravenous
      dexmedetomidine after procedure, and B group receive intravenous dexmedetomidine before
      procedure. Both group patients will hydrate 6 ml/kg crystalloid solution and will evaluated
      patient's anxiety and comfortability perioperative period. Vital signs will record 5 minutes
      interval at operating room and post-anesthetic care units.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">March 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor)</study_design>
  <primary_outcome>
    <measure>Hemodynamic effects</measure>
    <time_frame>During operation  and at post-anesthetic care unit (average of 4-5 hours)</time_frame>
    <safety_issue>No</safety_issue>
    <description>We compare heart rate, blood pressure, oxygen saturation, exhaled carbon dioxide concentration and bispectral index between two groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient's comfortability and anxiety</measure>
    <time_frame>during operation and at post-anesthetic care unit (average 4-5 hours)</time_frame>
    <safety_issue>No</safety_issue>
    <description>We measure korea version of state-trait anxiety inventory, comfortability (1=not comfortable,2=comfortable, 3=very comfortable) and visual analogue scale for patient's comfortability and anxiety.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">74</enrollment>
  <condition>Blood Pressure</condition>
  <condition>Anxiety</condition>
  <arm_group>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>IV dexmedetomidine infusion before intrathecal injection of heavy bupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexmedetomidine with heavy bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IV dexmedetomidine infusion after intrathecal injection of heavy bupivacaine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Dexmedetomidine infusion before intrathecal injection of heavy bupivacaine</description>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <other_name>Precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine with heavy bupivacaine</intervention_name>
    <description>Dexmedetomidine infusion after IT of heavy bupivacaine</description>
    <arm_group_label>Dexmedetomidine with heavy bupivacaine</arm_group_label>
    <other_name>Precedex</other_name>
    <other_name>Marcaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  20 - 60 aged patients

          -  orthopedic operation undergoing spinal anesthesia

        Exclusion Criteria:

          -  more than American society of anesthesiologists classification 3

          -  hypertension

          -  diabetes mellitus

          -  heart disease (bradycardia, atrioventricular block)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ki Hwa Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inje University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ki Hwa Lee, MD</last_name>
    <phone>82-51-797-0426</phone>
    <email>tedy333@paik.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Inje University, Haeundae paik hospital</name>
      <address>
        <city>Busan</city>
        <zip>612-896</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ki Hwa Lee, MD</last_name>
      <phone>82-51-797-0426</phone>
      <email>tedy333@paik.ac.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <lastchanged_date>June 3, 2014</lastchanged_date>
  <firstreceived_date>May 22, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Inje University</investigator_affiliation>
    <investigator_full_name>Ki Hwa Lee</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <keyword>Dexmedetomidine</keyword>
  <keyword>Spinal anesthesia</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
